Barclays’s Jupiter Wellness Acquisition Corp. Class A Common Stock JWAC Stock Holding History

Barclays’s Portfolio JWAC Stock Details JWAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-400,302	Closed	-$4.22M	–	5292
2023 Q1	$4.22M	Hold	400,302	–	–	﹤0.01%	1656
2022 Q4	$4.18M	Hold	400,302	–	–	﹤0.01%	1751
2022 Q3	$4.01M	Buy	400,302 +302	+0.1%	+$3.02K	﹤0.01%	1298
2022 Q2	$3.98M	Hold	400,000	–	–	﹤0.01%	1456
2022 Q1	$3.96M	Buy	+400,000	New	+$3.94M	﹤0.01%	1372

Barclays's JWAC Position: Q2 2023 in Review

Barclays sold out of Jupiter Wellness Acquisition Corp. Class A Common Stock (JWAC) in Q2 2023, closing a stake of 400,302 shares — an estimated $4.22M sold.

Barclays first reported a position in JWAC in Q1 2022 and held it in 5 quarters. The position peaked at $4.22M in Q1 2023. 0 funds tracked by Wall St. Rank hold JWAC as of Q2 2023.

Barclays reported no remaining Jupiter Wellness Acquisition Corp. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
Barclays sold 400,302 Jupiter Wellness Acquisition Corp. Class A Common Stock shares in Q2 2023, an estimated $4.22M.
Barclays first reported a position in Jupiter Wellness Acquisition Corp. Class A Common Stock in Q1 2022 and held it in 5 quarters.
Barclays's Jupiter Wellness Acquisition Corp. Class A Common Stock position peaked at $4.22M in Q1 2023.
0 funds tracked by Wall St. Rank held Jupiter Wellness Acquisition Corp. Class A Common Stock as of Q2 2023.

Based on Barclays's 13F filing for Q2 2023, filed 3 Aug 2023.